Latest in News & Research

Study Identifies Factors That Affect Antibiotic Prescribing for Acne

Five themes affect long-term prescribing, including perceived lack of evidence to justify change, discomfort discussing contraception

By Elana Gotkine (HealthDay News) | | April 11, 2024

Low Adherence to Follow-Up Seen for Primary Invasive Melanoma

Greater adherence to annual dermatology visits leads to reduced melanoma-specific mortality

By Dermsquared Editorial Team | | April 11, 2024

Oral Minoxidil Not Superior to Topical for Male Androgenetic Alopecia

Oral minoxidil can be an option for patients who would rather take an oral therapy or cannot tolerate topical treatment

By Dermsquared Editorial Team | | April 11, 2024

High-Strength Lidocaine Skin Creams Can Cause Seizures, Heart Trouble, FDA Warns

FRIDAY, March 29, 2024 (HealthDay News) -- Some pain-relieving skin products contain potentially harmful doses of the numbing agent lidocaine and should be avoided,...

By Dennis Thompson (HealthDay News) | | April 04, 2024

Model, Nomogram Predict Recurrence-Free, Melanoma-Specific Survival

Final model composed of six prognostic factors showed good prediction in development cohort and external validation

By Dermsquared Editorial Team | | April 03, 2024

Tildrakizumab Efficacious, Safe for Plaque Psoriasis of the Scalp

Significant improvement seen in IGA response and PSSI 90, with no serious treatment-related adverse events

By Dermsquared Editorial Team | | April 03, 2024

Second Primary Malignancy Risk Increased After Cutaneous B-Cell Lymphoma

Women have increased risk for thyroid, renal, lung cancers; men have highest risk for melanoma, bladder, prostate cancers

By Elana Gotkine (HealthDay News) | | April 03, 2024

Improved Prognosis Seen With Regression of Primary Cutaneous Melanoma

Findings seen in patients with primary cutaneous melanoma undergoing SLN biopsy and those who progressed to unresectable stage

By Dermsquared Editorial Team | | March 27, 2024

Do Skin Surface Temperature Measures Differ for Cellulitis, Pseudocellulitis?

Researchers find all skin surface temperature measures differ significantly between cellulitis and pseudocellulitis

By Dermsquared Editorial Team | | March 27, 2024

Social Media + Photo-Editing Apps Tied to Higher Interest in Cosmetic Procedures

Increases seen in social media use and cosmetic consultations during the COVID-19 pandemic

By Lori Solomon (HealthDay News) | | March 25, 2024

Survey Assesses Perspectives on Patient Image Use in Dermatology

Most patients report an increase in trust in quality of medical care if they were asked for consent to use medical image

By Elana Gotkine (HealthDay News) | | March 22, 2024

Wearable UV Dosimeter May Reduce Nonmelanoma Skin Cancer in Elderly

No significant reduction seen in incidence rates of actinic keratoses; no changes observed in anxiety, depression surveys

By Dermsquared Editorial Team | | March 20, 2024

AAD: Long-Term Safety, Efficacy Seen for Delgocitinib Cream in Hand Eczema

No safety concerns observed during 36 weeks of treatment with delgocitinib cream 20 mg/g

By Dermsquared Editorial Team | | March 20, 2024

AAD: Continuous Improvements Seen Through 68 Weeks for Deuruxolitinib in Alopecia

Proportion of patients achieving Severity of Alopecia Tool score ≤20 increased through 68 weeks of open-label extension

By Elana Gotkine (HealthDay News) | | March 19, 2024

Your Go-To Job Board for Critical Dermatology Support Roles

Finding the right talent for your dermatology practice is crucial for providing exceptional patient care and driving success. However, hiring dermatology support providers (like...

By myDermRecruiter | | March 18, 2024

AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe Alopecia

Patients achieving SALT score ≤20 increased from 44.5 to 75.8 percent at week 52 to week 76

By Tina Brown (HealthDay News) | | March 18, 2024

AAD: Lebrikizumab Shows Efficacy in Skin-of-Color Patients With Atopic Dermatitis

Among patients with atopic dermatitis and self-reported race other than White, 68.3 percent achieved EASI 75 at week 16

By Tina Brown (HealthDay News) | | March 18, 2024

AAD: Bimekizumab Response Durable at Four Years for Moderate-to-Severe Psoriasis

After four years of bimekizumab treatment, more than six in 10 patients achieved and maintained complete skin clearance

By Tina Brown (HealthDay News) | | March 15, 2024

AAD: Adult Acne Clinic Visits Increase With Exposure to Wildfire-Related Air Pollution

Rate of adult acne clinic visits 1.2-fold higher during 2018 California Camp Fire compared with nonfire weeks in 2015 and 2016

By Tina Brown (HealthDay News) | | March 15, 2024

AAD: Risk for Second Primary Malignancy Increased for Melanoma Patients

Melanoma survivors at greatest risk for cutaneous melanoma, ocular melanoma, thyroid, brain, prostate cancers

By Dermsquared Editorial Team | | March 13, 2024

Recommendations Developed for Managing Vitiligo in Young Patients

33 of 42 recommendations obtained 70 percent or higher composite agreement and strong agreement

By Dermsquared Editorial Team | | March 13, 2024

Atopic Dermatitis in Children Tied to Learning, Memory Difficulties

However, finding limited to children with neurodevelopmental comorbidities, like ADHD or learning disabilities

By Lori Solomon (HealthDay News) | | March 12, 2024

AAD: Concerns Noted Relating to Use of AI Dermatology Apps

None of the apps are approved by the FDA; only two include disclaimers for lack of regulatory approval

By Elana Gotkine (HealthDay News) | | March 08, 2024

24 of 1274

Headline from the Week of August 17 - 23, 2026

Peripheral Globules, Related Lesion Dynamics Predict Outcomes in Melanocytic Nevi

By Dermsquared Editorial Team | | August 18, 2026

Upadacitinib Has Positive Benefit-Risk Profile for Severe Alopecia Areata

By Dermsquared Editorial Team | | August 18, 2026